RecruitingNCT05841745

Multicenter Registry on Robotically Assisted PCI - TESLA

Multicenter Registry on Robotically Assisted Percutaneous Coronary Interventions - TESLA Registry

Sponsor

Clinical Research Center, Intercard Sp. z o.o.

Enrollment

700 participants

Start Date

Mar 1, 2023

Study Type

OBSERVATIONAL

Conditions

Coronary Artery Disease

Summary

MulTicenter rEgiStry on RoboticalLy Assisted percutaneous coronary interventions- TESLA registry is a retrospective registry evaluating the safety and efficacy of robotically assisted PCI with the CorPath GRX System (Corindus Vascular, Siemens Healthineers, Germany) in real-world interventional cardiology practice.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

Older than 18 years,
Patients with either stable coronary artery disease, unstable angina, or acute myocardial infarction (MI),
Coronary artery lesions considered suitable for R-PCI with CorPath GRX System.

Exclusion Criteria1

\- Unwillingness to provide informed consent (only if applicable).

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICERobotically-Assisted Percutaneous Coronary Intervention with CorPath GRX System

The CorPath GRX System is intended for use in the remote delivery and manipulation of guidewires and rapid exchange catheters, and remote manipulation of guide catheters during percutaneous coronary and vascular procedures. The CorPath GRX System is composed of two units; the first is a bedside unit which consists of the extended robotic arm, robotic drive, and single-use loading cassette, and the second is the remote workstation, which consists of the interventional cockpit and the control console. A key innovation of the CorPath GRX System is the software-based automation of common maneuvers, called technIQ automated movements with the potential to increase procedural success, reduce procedure time, and generally increase user comfort with robotic assistance during PCI.